| 000 | 01563 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250515010433.0 | ||
| 264 | 0 | _c20060420 | |
| 008 | 200604s 0 0 eng d | ||
| 022 | _a0378-5173 | ||
| 024 | 7 |
_a10.1016/j.ijpharm.2005.10.036 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLegen, Igor | |
| 245 | 0 | 0 |
_aThe evaluation of some pharmaceutically acceptable excipients as permeation enhancers for amoxicillin. _h[electronic resource] |
| 260 |
_bInternational journal of pharmaceutics _cFeb 2006 |
||
| 300 |
_a84-9 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 |
_aAmoxicillin _xmetabolism |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xmetabolism |
| 650 | 0 | 4 |
_aBenzbromarone _xpharmacology |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aElectric Conductivity |
| 650 | 0 | 4 |
_aExcipients _xpharmacology |
| 650 | 0 | 4 |
_aGlucose _xpharmacology |
| 650 | 0 | 4 | _aHydrogen-Ion Concentration |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aIntestinal Absorption _xdrug effects |
| 650 | 0 | 4 |
_aJejunum _xdrug effects |
| 650 | 0 | 4 |
_aMultidrug Resistance-Associated Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aSodium Dodecyl Sulfate _xpharmacology |
| 700 | 1 | _aKracun, Matjaz | |
| 700 | 1 | _aSalobir, Mateja | |
| 700 | 1 | _aKerc, Janez | |
| 773 | 0 |
_tInternational journal of pharmaceutics _gvol. 308 _gno. 1-2 _gp. 84-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ijpharm.2005.10.036 _zAvailable from publisher's website |
| 999 |
_c15951753 _d15951753 |
||